Drug-resistant infections are killing tens of thousands of Americans each year, and the Centers for Disease Control and Prevention says the threat is climbing.
Story Snapshot
- The Centers for Disease Control and Prevention ranked 18 drug-resistant germs by threat level in a national assessment.
- The agency estimates more than 2.8 million resistant infections and over 35,000 deaths in the United States each year.
- Adding Clostridioides difficile brings the toll near 50,000 deaths annually in some agency materials.
- Drug-resistant Candida auris and carbapenem-resistant Acinetobacter are classified as urgent threats.
CDC’s latest threat map: who, what, how many
The Centers for Disease Control and Prevention released a national report that ranks drug-resistant bacteria and fungi as urgent, serious, or concerning threats. The report lists 18 germs and explains why each earned its spot. Two new names jumped to the top tier: drug-resistant Candida auris and carbapenem-resistant Acinetobacter. Both spread in hospitals and nursing homes and often defeat many medicines. The agency estimates more than 2.8 million resistant infections and over 35,000 deaths each year.
The report also addresses a related killer, Clostridioides difficile. This infection often follows antibiotic use that wipes out helpful gut bacteria. It is not usually resistant itself, but it rides the wake of heavy antibiotic use. Counting C. difficile with resistant infections brings the total burden in some Centers for Disease Control and Prevention materials to about 48,000 to 50,800 deaths yearly, alongside millions more infections. That broader picture shows the full cost of misused antibiotics.
Why two big numbers both matter
Readers will see two headline numbers: over 35,000 deaths from resistant infections, and about 50,000 deaths when including C. difficile. Both come from Centers for Disease Control and Prevention documents, but they describe different slices of the problem. The first focuses on deaths from bacteria and fungi that shrug off drugs. The second adds deaths tied to antibiotic disruption of the gut. News reports sometimes compress these into one line, which can blur the categories.
The Centers for Disease Control and Prevention says its 2019 assessment used better data than the 2013 version. The improved sources raised the estimated burden but also showed progress against some threats. The agency said annual deaths were nearly twice what the 2013 report suggested, even as targeted work drove declines in key settings. This is how better measurement works: wider lenses see more, while focused action can still cut risk in hotspots.
The four-alarm germs: why these rise to “urgent”
Drug-resistant Candida auris spreads across health facilities because it clings to surfaces and survives lapses in cleaning. It also resists several antifungals, leaving few options when it invades the bloodstream. Carbapenem-resistant Acinetobacter exploits ventilators, catheters, and wounds, and it often resists many drug classes. The Centers for Disease Control and Prevention elevated both to “urgent” because of spread, limited treatments, and severe outcomes in fragile patients. These labels guide hospitals on where to aim resources first.
These superbugs pose the biggest threat to Americans, CDC says.
Nineteen drug-resistant germs cause an estimated 9.7 million infections and 50,800 deaths in the country each year.https://t.co/bwhAipXLPe
— Richard H. Ebright (@R_H_Ebright) October 28, 2026
The Centers for Disease Control and Prevention’s ranking weighs clinical harm, spread in healthcare, treatment limits, and the chance the threat will grow. That is a practical approach. It flags germs where quick action saves lives and money. Americans expect a system that rewards personal responsibility and accountability. This is that, in public health form: clean hands, clean rooms, tight prescribing, and fast reporting. These steps protect patients and respect taxpayers by avoiding wasteful, last-minute care.
What action looks like at the bedside and at home
Hospitals can harden their defenses now. Screen high-risk patients on entry. Isolate and cohort when needed. Clean rooms with checklists and audits. Share lab data in hours, not days. Stewardship teams should stop antibiotics that do not fit the bug. Families can do their part, too. Do not demand antibiotics for a cold. Take every pill when prescribed. Ask if a test can confirm the infection. Wash hands after bathroom visits and before meals. Small habits block big threats.
Policy makers can target what works. Fund rapid testing in emergency rooms and long-term care. Back domestic drug manufacturing to avoid shortages. Support data systems that track outbreaks in real time. Tie payment to infection control performance. These steps reflect common sense: prevent first, treat smart, and track results. The Centers for Disease Control and Prevention’s figures—35,000 deaths from resistance, and nearly 50,000 when including C. difficile—are not scare lines. They are a scoreboard we can move with discipline and focus.
Sources:
archive.cdc.gov, cdc.gov, stacks.cdc.gov
